| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |